Trivasc

Trivasc

trimetazidine

Manufacturer:

Lloyd

Distributor:

Aldril

Marketer:

TotalCare
Concise Prescribing Info
Contents
Trimetazidine diHCl
Indications/Uses
Angina pectoris & ischaemia of neurosensorial tissues as in Meniere's disease.
Dosage/Direction for Use
1 tab bid, once in the morning & once in the evening. Moderate renal impairment (CrCl 30-60 mL/min) 35 mg in the morning.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Pregnancy & lactation.
Special Precautions
Not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris or MI, nor in pre-hospital phase or during the 1st days of hospitalization. May aggravate or cause symptoms similar to those of Parkinson's disease. Parkinsonian symptoms persist >4 mth after discontinuation. May affect ability to drive & use machines. Moderate renal impairment. Not to be administered in childn <18 yr. Elderly (>75 yr).
Adverse Reactions
Rarely, GI disorders eg, nausea & vomiting.
MIMS Class
Anti-Anginal Drugs
ATC Classification
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Trivasc MR tab 35 mg
Packing/Price
100's (P1,090/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in